Patents by Inventor Chang-Hee Moon

Chang-Hee Moon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition containing horse chestnut extract
    Patent number: 9962331
    Abstract: The present invention relates to a composition containing Horse chestnut extract that inhibits angiogenesis and matrix metalloproteinase activity. The Horse chestnut extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat and prevent disease related to angiogenesis and/or matrix metalloproteinase.
    Type: Grant
    Filed: April 26, 2004
    Date of Patent: May 8, 2018
    Assignee: Angiolab, Inc.
    Inventors: Min-Young Kim, Byung-Young Park, Chang-Hee Moon, Eun-Kyu Park, Kyoung-Mi Kim
  • Composition comprising leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
    Patent number: 7485327
    Abstract: The present invention relates to a composition comprising Melissa leaf extract that inhibits angiogenesis and matrix metalloproteinase activity. The Melissa leaf extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat or prevent diseases related to angiogenesis and matrix metalloproteinase. The composition of the present invention comprising Melissa leaf extract may also comprise more than one component of the other anti-angiogenic, anti-cancer, anti-inflammatory and anti-aging components. This particular composition comprising Melissa leaf extract can be used for pharmaceutical, dietetic and/or cosmetic purposes.
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: February 3, 2009
    Assignee: AngioLab, Inc.
    Inventors: Min-Young Kim, Byung-Young Park, Chang-Hee Moon, Eun-Kyu Park, Kyoung-Mi Kim
  • Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
    Patent number: 7413735
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained from Mycoplasma arginini or prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: August 19, 2008
    Assignee: Angio Lab, Inc.
    Inventors: Bon-Hong Min, Myung-Ok Park, Min-Young Kim, Byung-Young Park, Boe-Gwun Chun, Sang-Wook Kang, Chang-Hee Moon
  • Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
    Publication number: 20060002915
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained from Mycoplasma arginini or prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.
    Type: Application
    Filed: June 20, 2005
    Publication date: January 5, 2006
    Inventors: Bon-Hong Min, Myung-Ok Park, Min-Young Kim, Byung-Young Park, Boe-Gwun Chun, Sang-Wook Kang, Chang-Hee Moon
  • Composition containing horse chestnut extract
    Publication number: 20040234633
    Abstract: The present invention relates to a composition containing Horse chestnut extract that inhibits angiogenesis and matrix metalloproteinase activity. The Horse chestnut extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat and prevent disease related to angiogenesis and/or matrix metalloproteinase.
    Type: Application
    Filed: April 26, 2004
    Publication date: November 25, 2004
    Inventors: Min-Young Kim, Byung-Young Park, Chang-Hee Moon, Eun-Kyu Park, Kyoung-Mi Kim
  • Compositon containg ginkgo biloba that inhibit angiogenesis and matrix metalloprotinase
    Publication number: 20040101578
    Abstract: The present invention relates to a composition containing ginkgo biloba extract that inhibit angiogenesis and matrix metalloproteinases. The ginkgo biloba extract of the present invention suppress angiogenesis and activity of matrix metalloproteinases, so that it can be applied to medicine for disease related in angiogenesis and matrix metalloproteinases.
    Type: Application
    Filed: February 4, 2003
    Publication date: May 27, 2004
    Inventors: Min-Young Kim, Byung-Young Park, Chang-Hee Moon, Eun-Kyu Park
  • Pharmaceutical composition comprising arginine deiminasa for inhibiting angio-genesis
    Publication number: 20040096437
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained from Mycoplasma arginini or prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.
    Type: Application
    Filed: January 24, 2003
    Publication date: May 20, 2004
    Inventors: Bon-Hong Min, Myung-Ok Park, Min-Young Kim, Byung-Young Park, Boe-Gwun Chun, Sang-Wook Kang, Chang-Hee Moon
  • Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
    Publication number: 20040009244
    Abstract: The present invention relates to a composition comprising Melissa leaf extract that inhibits angiogenesis and matrix metalloproteinase activity. The Melissa leaf extract of the present invention inhibits angiogenesis and activity of matrix metalloproteinase, so that it can be applied to treat or prevent diseases related to angiogenesis and matrix metalloproteinase. The composition of the present invention comprising Melissa leaf extract may also comprise more than one component of the other anti-angiogenic, anti-cancer, anti-inflammatory and anti-aging components. This particular composition comprising Melissa leaf extract can be used for pharmaceutical, dietetic and/or cosmetic purposes.
    Type: Application
    Filed: June 12, 2003
    Publication date: January 15, 2004
    Inventors: Min-Young Kim, Byung-Young Park, Chang-Hee Moon, Eun-Kyu Park, Kyoung-Mi Kim
  • Anti-angiogenic composition comprising ticlopidine and gingko biloba extract
    Publication number: 20030165586
    Abstract: A composition comprising ticlopidine and a Ginkgo biloba extract is used in the manufacture of a medicine for inhibiting angiogenesis, which has an enhanced anti-angiogenic activity with reduced side effect.
    Type: Application
    Filed: January 27, 2003
    Publication date: September 4, 2003
    Inventors: Min-Young Kim, Byung-Young Park, Chang-Hee Moon